Amylyx Pharmaceuticals, Inc.AMLXNASDAQ
Loading
Debt to Assets Over TimeCompressed
Percentile Rank67
3Y CAGR+3.8%
5Y CAGR-29.3%
Year-over-Year Change
Debt-to-assets ratio
3Y CAGR
+3.8%/yr
Annual compound
5Y CAGR
-29.3%/yr
Recent acceleration
Percentile
P67
Within normal range
vs 5Y Ago
0.2x
Contraction
Streak
2 yr
Consecutive growthCompressed
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 0.02 | +75.0% |
| 2024 | 0.01 | +24.9% |
| 2023 | 0.01 | -48.9% |
| 2022 | 0.02 | - |
| 2021 | 0.00 | -100.0% |
| 2020 | 0.10 | -97.8% |
| 2019 | 4.64 | - |